title: Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer.
abstract: The epidermal growth factor (EGF) receptors play an important role in epithelial cell function. Upon stimulation of these receptors, an extensive network of signal transduction pathways is activated, including the PI3K/AKT and Ras/Erk pathways. This activation leads to cellular proliferation and survival. In breast cancer, the EGF receptor, ErbB2 (HER2/neu), can be amplified and over-expressed and this is associated with poor prognosis and drug resistance. Trastuzumab is a monoclonal antibody against ErbB2 and has demonstrated activity in the therapy of breast cancer patients with over-expression of ErbB2, both in the metastatic and adjuvant setting. Recently, a tyrosine kinase inhibitor, lapatinib, that targets both ErbB1 and ErbB2, has also shown activity in metastatic breast cancer. In this review, we will discuss the ErbB receptors and their signaling networks in breast cancer, as well as the clinical activities of trastuzumab and lapatinib in this disease.
authors.affiliation: Manitoba Institute of Cell Biology, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada.
authors.forename: Elizabeth S
authors.initials: ES
authors.lastname: Henson
authors.forename: James B
authors.initials: JB
authors.lastname: Johnston
authors.forename: Marek
authors.initials: M
authors.lastname: Los
authors.forename: Spencer B
authors.initials: SB
authors.lastname: Gibson
references.citation: Cancer Res. 2006 Feb 1;66(3):1630-9
references.pmid: 16452222
references.citation: Cell. 1999 Mar 19;96(6):857-68
references.pmid: 10102273
references.citation: Cancer Res. 2006 Feb 1;66(3):1640-7
references.pmid: 16452223
references.citation: Oncogene. 1998 Mar;16(11):1493-9
references.pmid: 9580112
references.citation: Virchows Arch. 2005 May;446(5):475-82
references.pmid: 15856292
references.citation: Nat Cell Biol. 2001 Nov;3(11):973-82
references.pmid: 11715018
references.citation: Cancer Res. 2006 Jul 15;66(14):7245-52
references.pmid: 16849573
references.citation: J Clin Oncol. 1999 Sep;17(9):2639-48
references.pmid: 10561337
references.citation: Drugs Today (Barc). 2003;39 Suppl C:61-80
references.pmid: 14988746
references.citation: J Clin Oncol. 1996 Mar;14(3):737-44
references.pmid: 8622019
references.citation: J Clin Oncol. 2001 May 15;19(10):2587-95
references.pmid: 11352950
references.citation: EMBO J. 2000 Jul 3;19(13):3159-67
references.pmid: 10880430
references.citation: Cancer Res. 2005 Dec 1;65(23):11118-28
references.pmid: 16322262
references.citation: J Clin Oncol. 2004 Jul 15;22(14):2954-63
references.pmid: 15254063
references.citation: Breast Cancer. 2007;14(2):156-62
references.pmid: 17485900
references.citation: Nat Rev Cancer. 2005 May;5(5):341-54
references.pmid: 15864276
references.citation: Curr Med Chem. 2006;13(29):3483-92
references.pmid: 17168718
references.citation: Oncogene. 2007 May 28;26(25):3637-43
references.pmid: 17530017
references.citation: Cancer Cell. 2005 Apr;7(4):351-62
references.pmid: 15837624
references.citation: Oncologist. 2006 Nov-Dec;11(10):1047-57
references.pmid: 17110623
references.citation: J Cell Biochem. 2003 Aug 15;89(6):1177-92
references.pmid: 12898516
references.citation: Int J Radiat Oncol Biol Phys. 2004;59(2 Suppl):21-6
references.pmid: 15142631
references.citation: Semin Cancer Biol. 2003 Aug;13(4):267-73
references.pmid: 14563121
references.citation: Clin Lymphoma Myeloma. 2007 Mar;7 Suppl 2:S81-4
references.pmid: 17382017
references.citation: Cancer Res. 2005 Aug 15;65(16):7052-8
references.pmid: 16103051
references.citation: Biochem Biophys Res Commun. 2005 Jun 10;331(3):851-8
references.pmid: 15865941
references.citation: Curr Opin Chem Biol. 2005 Jun;9(3):325-31
references.pmid: 15939336
references.citation: Mol Cell. 2003 Sep;12(3):541-52
references.pmid: 14527402
references.citation: Clin Cancer Res. 1996 Jul;2(7):1215-9
references.pmid: 9816290
references.citation: J Natl Cancer Inst. 2007 Mar 7;99(5):348-9
references.pmid: 17341725
references.citation: Cancer Res. 2005 Jan 1;65(1):18-25
references.pmid: 15665275
references.citation: Mol Cell Biol. 1999 Sep;19(9):6195-206
references.pmid: 10454566
references.citation: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7795-800
references.pmid: 16682622
references.citation: Drugs. 2007;67(9):1329-41
references.pmid: 17547474
references.citation: Curr Drug Targets. 2005 May;6(3):243-57
references.pmid: 15857286
references.citation: Oncogene. 2004 Jan 22;23(3):646-53
references.pmid: 14737100
references.citation: J Cell Mol Med. 2005 Jan-Mar;9(1):59-71
references.pmid: 15784165
references.citation: Oncogene. 2001 Mar 22;20(12):1465-75
references.pmid: 11313890
references.citation: Br J Cancer. 2004 Oct 18;91(8):1420-4
references.pmid: 15365568
references.citation: J Clin Oncol. 2002 Feb 1;20(3):719-26
references.pmid: 11821453
references.citation: J Natl Cancer Inst. 2007 May 2;99(9):694-705
references.pmid: 17470737
references.citation: Oncogene. 2002 Sep 12;21(41):6255-63
references.pmid: 12214266
references.citation: Exp Cell Res. 2002 Jan 15;272(2):192-8
references.pmid: 11777344
references.citation: Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):344-52
references.pmid: 14751502
references.citation: Mol Cancer Ther. 2007 Feb;6(2):667-74
references.pmid: 17308062
references.citation: Crit Rev Oncol Hematol. 2007 Apr;62(1):53-61
references.pmid: 17324578
references.citation: Cancer Res. 2004 Apr 1;64(7):2343-6
references.pmid: 15059883
references.citation: Ann Oncol. 2001 Jun;12(6):745-60
references.pmid: 11484948
references.citation: N Engl J Med. 2006 Dec 28;355(26):2733-43
references.pmid: 17192538
references.citation: J Clin Oncol. 2002 Apr 1;20(7):1800-8
references.pmid: 11919237
references.citation: Nature. 2002 Aug 29;418(6901):934
references.pmid: 12198537
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19063-8
references.pmid: 17148612
references.citation: N Engl J Med. 2005 Oct 20;353(16):1659-72
references.pmid: 16236737
references.citation: N Engl J Med. 2001 Mar 15;344(11):783-92
references.pmid: 11248153
references.citation: N Engl J Med. 2005 Oct 20;353(16):1673-84
references.pmid: 16236738
references.citation: Physiol Rev. 1999 Jan;79(1):143-80
references.pmid: 9922370
references.citation: Mol Cell Biol. 1999 Oct;19(10):6845-57
references.pmid: 10490623
references.citation: Science. 1993 Nov 12;262(5136):1065-9
references.pmid: 7694366